Erratum: Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition: Erratum.

Qi Wang Juan Liu Yinan Hu Ting Pan Yongjian Xu Jun Yu Weining Xiong Qing Zhou Yi Wang

Theranostics

Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of National Health Commission, Key Site of National Clinical Research Center for Respiratory Disease, Wuhan Clinical Medical Research Center for Chronic Airway Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, 1095 Jiefang Ave, Wuhan 430030, China.

Published: July 2022

[This corrects the article DOI: 10.7150/thno.61085.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330520	PMC
http://dx.doi.org/10.7150/thno.74512	DOI Listing

Publication Analysis

Top Keywords

erratum local

local administration

administration liposomal-based

liposomal-based srpx2

srpx2 gene

gene therapy

therapy reverses

reverses pulmonary

pulmonary fibrosis

fibrosis blockading

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!